Last updated 2026-07-20
- Raised $7M Seed round led by OurCrowd, Apr 2022
- Raised $1.3M grant, Dec 2023
Total raised
$8.3M
Last: Grant 2024-01
Stage
Seed
Founded
2021
Headcount
7
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Sequentify is an Israeli medtech startup that develops genomic sample processing products and technologies for Next-Generation Sequencing (NGS). The company, a spin-off from the Weizmann Institute of Science, combines synthetic biology and AI software to enable fast, cost-effective, and automated targeted DNA sequencing. Their proprietary InfiniSeq platform offers solutions for cancer diagnostics, carrier screening, COVID-19 surveillance, and infectious disease research, with a focus on the clinical market. Sequentify aims to make genomics as common and affordable as blood tests, facilitating the decentralization of NGS into local labs and hospitals.
Funding history · 2 rounds · $8.3M total
2023-12
Grant
$1.3M
2022-04
Seed
$7.0M
★ OurCrowd
Headcount over time
From 2 (2021-04) to 7 (2026-07) · +5 (+250%) · 22 points · source: Finder history + radar grounding
Q&A
- What is Sequentify's primary focus?
- Sequentify develops novel library-prep solutions for next-generation sequencing, focusing on genomic sample processing products and technologies prior to sequencing hardware loading.
- When was Sequentify founded?
- Sequentify was founded in January 2021.
- Where is Sequentify headquartered?
- Sequentify is headquartered in Rehovot, Israel.
- How many employees does Sequentify have?
- Sequentify has 1-10 employees.
- What is Sequentify's total funding to date?
- Sequentify has raised a total of $11,100,000 USD.
- When did Sequentify receive its most recent funding?
- Sequentify received a grant of $1,300,000 USD in January 2024.
- Which investor participated in Sequentify's funding rounds in 2022?
- OurCrowd participated in Sequentify's funding rounds in May and September 2022.
- Who are the co-founders of Sequentify?
- The co-founders of Sequentify are Tom Fleischer (Co-founder & CEO) and Tamir Biezuner (Co-founder & CSO).
Team · 3
Tamir Biezuner
Founder · Co-Founder and Chief Scientific Officer
Tom Fleischer
Founder · Co-Founder and Chief Executive Officer
Ophir Herbst
Founder · Co-Founder and CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
genomicsdiagnosticsmedical-technologiescancerbiotechnologypersonalized-medicineoncology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sequentify.com/ |
|---|---|
| linkedin.com/company/69241268 |
Identifiers & details
| Legal name | Sequentify Ltd. |
|---|---|
| Founded | 2021 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | sequentify.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516309572 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-01-06 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — violation (1), people (2), annual_report (1) |
| Registered address | קינד מוטי 10 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-11 | עדכון הפרה |
| 2025-08-11 | עדכון דירקטורים-הסרת דירקטור |
| 2025-08-11 | דו~ח שנתי |
| 2025-08-11 | עדכון דירקטורים-הוספת דירקטור |